Aridis Pharmaceuticals Receives Nasdaq Notice on Late Filing of its Form 10-Q
25 mai 2023 16h05 HE
|
Aridis Pharmaceuticals, Inc.
LOS GATOS, Calif., May 25, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) (“Aridis” or the “Company”), a biopharmaceutical company, announced today that it received a notice...